LOXL4 Abrogation Does Not Exaggerate Angiotensin II-Induced Thoracic or Abdominal Aortic Aneurysm in Mice.
Huimin LiJun GuoYiting JiaWei KongWei LiPublished in: Genes (2021)
It has been shown that thoracic aortic aneurysm and dissection (TAAD) could be a Mendelian trait caused by a single gene mutation. The LOX gene mutation leads to the development of human TAAD. The LOXL4 gene is a member of the lysyl oxidase gene family. We identified seven variants in the LOXL4 gene in 219 unrelated patients with TAAD by whole-exome sequencing (WES). To further investigate whether LOXL4 is a candidate causative gene for human TAAD, a LOXL4 knockout mouse was generated, and the mutant mice were treated by subcutaneous infusion of angiotensin II. We found that abrogation of LOXL4 did not induce a more severe thoracic or abdominal aortic aneurysm compared with the wild-type C57BL/6J mice. Our results suggest that LOXL4 may not play a major role in the development of angiotensin II-induced aortic aneurysm. The functional study using this animal model system is important for the evaluation of candidate genes of TAAD identified by WES.
Keyphrases
- angiotensin ii
- wild type
- abdominal aortic aneurysm
- aortic aneurysm
- angiotensin converting enzyme
- vascular smooth muscle cells
- endothelial cells
- copy number
- genome wide
- high glucose
- spinal cord
- high fat diet induced
- drug induced
- genome wide identification
- low dose
- pluripotent stem cells
- type diabetes
- early onset
- oxidative stress
- skeletal muscle
- transcription factor
- cord blood
- gene expression